Bacteria-triggered tumor-specific thrombosis to enable potent photothermal immunotherapy of cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bacteria-triggered tumor-specific thrombosis to enable potent photothermal immunotherapy of cancer
Authors
Keywords
-
Journal
Science Advances
Volume 6, Issue 33, Pages eaba3546
Publisher
American Association for the Advancement of Science (AAAS)
Online
2020-08-15
DOI
10.1126/sciadv.aba3546
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
- (2019) Qian Chen et al. ADVANCED MATERIALS
- Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study
- (2019) Ardeshir R. Rastinehad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bacteria-Driven Hypoxia Targeting for Combined Biotherapy and Photothermal Therapy
- (2018) Wenfei Chen et al. ACS Nano
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies
- (2018) Shetal A. Patel et al. IMMUNITY
- Immunotherapy: Oncolytic viruses prime antitumour immunity
- (2018) Diana Romero Nature Reviews Clinical Oncology
- How to eliminate gastric cancer-related death worldwide?
- (2018) Yoshio Yamaoka Nature Reviews Clinical Oncology
- Urothelial cancer: Optimizing and integrating cisplatin-based chemotherapy across the disease spectrum
- (2018) Jay D. Raman Nature Reviews Urology
- Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
- (2018) Rui Kuai et al. Science Advances
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Two-step enhanced cancer immunotherapy with engineeredSalmonella typhimuriumsecreting heterologous flagellin
- (2017) Jin Hai Zheng et al. Science Translational Medicine
- Bacteria-Mediated Hypoxia-Specific Delivery of Nanoparticles for Tumors Imaging and Therapy
- (2016) Cheng-Hung Luo et al. NANO LETTERS
- Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions
- (2016) Ouajdi Felfoul et al. Nature Nanotechnology
- Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
- (2016) Qian Chen et al. Nature Communications
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Covalent Binding of Nanoliposomes to the Surface of Magnetotactic Bacteria for the Synthesis of Self-Propelled Therapeutic Agents
- (2014) Samira Taherkhani et al. ACS Nano
- Differential Anticancer Drug Delivery with a Nanogel Sensitive to Bacteria-Accumulated Tumor Artificial Environment
- (2013) Meng-Hua Xiong et al. ACS Nano
- Nontoxic radioactive Listeriaat is a highly effective therapy against metastatic pancreatic cancer
- (2013) W. Quispe-Tintaya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
- (2013) N. Iida et al. SCIENCE
- Flagellin enhances tumor-specific CD8+ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model
- (2013) Chung Truong Nguyen et al. VACCINE
- Bacteria-Induced Gap Junctions in Tumors Favor Antigen Cross-Presentation and Antitumor Immunity
- (2010) F. Saccheri et al. Science Translational Medicine
- Tumor Invasion of Salmonella enterica Serovar Typhimurium Is Accompanied by Strong Hemorrhage Promoted by TNF-α
- (2009) Sara Leschner et al. PLoS One
- Salmonella enterica Serovar Gallinarum Requires ppGpp for Internalization and Survival in Animal Cells
- (2008) J.-H. Jeong et al. JOURNAL OF BACTERIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started